MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Rapidly onset progressive generalised dystonia parkinsonism in a young Indian male with rare FBXO 7 genetic mutation

    S. Desai, N. Pampaniya, K. Mori, K. Shah (Vadodara, India)

    Objective: To describe a rare case of rapidly progressive generalized dystonia parkinsonism due to FBXO7 gene mutation. Background: Parkinson’s disease is a neurodegenerative disorder of…
  • 2019 International Congress

    Cerebrotendinous Xanthomatosis presenting Parkinsonism with bilateral iron accumulation in the basal ganglia

    J. Li, S. Liu, E. Xu, H. Qiao, W. Mao, P. Chan (Beijing, China)

    Objective: Cerebrontendinous xanthomatosis(CTX) is a treatable, autosomal recessive, lipid storage disorder  disease. Herein, we present a case of CTX. It aims to refresh and improve…
  • 2019 International Congress

    A detailed delineation of the clinical phenotype, natural history and quality of life in patients with North Sea Progressive Myoclonus Epilepsy

    S. Polet, L. Koens, M. van Egmond, D. Sival, E. Brusse, M. Willemsen, R. Lambrechts, O. Brouwer, G. Drost, H. Kremer, J. de Vries, M. de Koning-Tijssen, T. de Koning (Groningen, Netherlands)

    Objective: To report for the first time on a detailed description of the phenotype, natural history and quality of life (QoL) in a relatively large…
  • 2019 International Congress

    Restoring AADC enzyme synthesis in AADC deficiency: MRI-Guided Delivery of AAV2-hAADC Gene Therapy to the Midbrain

    K. Bankiewicz, T. Pearson, A. Grijalvo-Perez, A. Viehoever, W. San Sebastian, J. Imamura-Ching, Y. Seo, P. Larson, N. Gupta (San Francisco, CA, USA)

    Objective: Evaluate the safety and efficacy of real-time MR-guided delivery of adeno-associated virus serotype 2 (AAV2)-hAADC delivery to the SNc and VTA for the treatment…
  • 2019 International Congress

    A Case of Diurnally Variable Gut Discomfort in a Patient with RLS

    J. Coleman, A. Amara (Birmingham, AL, USA)

    Objective: To report the case of a man with restless legs syndrome (RLS) manifesting as predominantly gastrointestinal discomfort. Background: RLS is an unpleasant urge to…
  • 2019 International Congress

    Automatic quantification of micro-sleep stability in isolated REM sleep behavior disorder and Parkinson’s disease

    M-L. Muntean, M. Cesari, F. Sixel-Döring, B. Mollenhauer, JAE. Christensen, HBD. Sorensen, PJJ. Jennum, C. Trenkwalder (Kassel, Germany)

    Objective: To investigate micro-sleep stability in patients with Parkinson’s disease (PD) with REM sleep behavior disorder (PD+RBD), PD patients without RBD (PDnoRBD), patients with isolated…
  • 2019 International Congress

    Dyadic analysis of the Parkinson’s disease impact on the patient-spouse couple

    E. Constant, E. Brugallé, E. Wawrziczny, B. Flinois, K. Dujardin, P. Antoine (Villeneuve D'Ascq, France)

    Objective: The present research aims to understand the dyadic functioning of couples faced with Parkinson’s disease (PD) considering disease progression. Background: PD has detrimental effects…
  • 2019 International Congress

    Considerations before initiating therapy in Parkinsonism: basing on the health-related quality of life.

    FT. Liu, J. Wang (Shanghai, China)

    Objective: We aimed to compare the determinants of life quality between drug naïve PD and MSA-P patients. Background: To improve the quality of life (QoL)…
  • 2019 International Congress

    Impact of cathine and carthinone use among Parkinson’s disease Patients

    S. Zewde (Addis Ababa, Ethiopia)

    Objective: Evaluate cathine and cathinone’s effect on alertness, energy, sleep pattern, and tremor among Parkinson’s disease patient. Background: Khat, a plant that contains amphetamine like…
  • 2019 International Congress

    Evaluating Implementation of an Evidence-based Physical and Occupational Therapy (LSVT BIG®) for Parkinson’s Disease: Germany, France and Japan

    C. Fox, L. Guse, L. Ramig (Tucson, AZ, USA)

    Objective: To evaluate implementation of LSVT BIG across diverse health care systems, languages, and culture in Germany, France and Japan. Background: The goal of implementation…
  • « Previous Page
  • 1
  • …
  • 66
  • 67
  • 68
  • 69
  • 70
  • …
  • 217
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Welcome to the MDS Abstracts Site
  • Life expectancy with and without Parkinson’s disease in the general population
  • Nilotinib for treating MSA: A preclinical proof of concept study
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley